Wynnefield Capital Discloses About 14.3% Stake In Lifecore Biomedical, Agrees To Vote In Favor Of Its Pending Merger, Per 13D Filing

Wynnefield Capital has disclosed a 14.3% stake in Lifecore Biomedical (ticker: LFCR) and has agreed to vote in favor of the company's pending merger, according to a recent 13D filing. This strategic move indicates support for Lifecore's upcoming merger plans.